HLA-G and cancer: Therefore, regarding the growing and successful use of antibodies against checkpoints such as anti-CTLA-4 and anti- PD-L1/PD-1 to restore antitumor immunity [35], HLA-G appears as a wider and promising relevant target for cancer immunotherapy [12].